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Introduction
A woman's lifetime risk of acquiring HPV infection is higher than 80%, and most infections occur within 3-4 years of sexual debut [1] . The principal burden of HPV infections globally has been cervical cancer.
HPV infections are observed in over 99% of patients with cervical cancer [2] . Globally, cervical cancer is the fourth most common cancer among women affecting 500,000 women annually. In 2012, globally, there was up to 528,000 new cases of cervical cancer and 266,000 deaths [3] . In developing countries, cervical cancer accounts for 12% of female cancers and these contribute 80% of global cervical cancer cases [3] . The World Health Organization recommends HPV vaccination for girls aged 9-14 years as the most cost-effective public health intervention against cervical cancer. In Uganda, cervical cancer ranks as the most frequent cancer among women aged between 14 and 15 years. The age-standardised incidence rate of cervical cancer is high at 47.5/100,000 [4] . Despite this, many girls and women in Uganda stay without routine HPV vaccination and cervical cancer screenings because of lack of awareness, limited availability of vaccination and screening programs [5, 6] . Therefore more than three-quarters of cervical cancer patients in Uganda report with advanced disease conditions [7] . In Uganda, HPV vaccination was first piloted in 2008 in Nakasongola and Ibanda districts. It was later piloted in 12 other districts in 2012. The success of these pilot projects paved the way for countrywide scale-up of HPV vaccination before the end of 2015 and is now integrated into the national routine immunisation program [8] . Lira district is one of the first 12 districts where HPV vaccination was piloted. This study assessed the level and the factors associated with uptake of HPV vaccine by female adolescent girls in Lira district, Uganda to inform implementation of the HPV vaccine program in Uganda.
Methods
Study area and design: we employed a mixed methods approach in which quantitative and qualitative data were collected using a concurrent triangulation design. By combining quantitative and qualitative data, we sought convergence and corroboration among the different data sources. The multiple perspectives provided an opportunity to develop a complete understanding of the factors associated with uptake of HPV vaccination. This study was conducted in Lira district, Northern Uganda in May 2016. Lira district is one of the 12 districts where the HPV vaccination program was first implemented (piloted) in Uganda in 2012, so the program was four years old at the time of this study.
Study population: the study enrolled female adolescents aged 12-17 years because they were expected to have completed the vaccination schedule.
Quantitative study: quantitative data were collected in a multistage cross-sectional design. The required sample size of 460 was determined using the formula by Bennett et al. (1991) [9] for cluster surveys with the following assumptions; a precision of 0.032 as was used in a study by Turner (2003) , type I error of 5%, prevalence of uptake at 50% PATH et al, (2011) [10], 10 households per village and a design effect of 1.9. This study used a three-stage sampling procedure; at the first stage, we randomly selected four sub-counties out of the 13 in the district (i.e, two rural and two urban). At the second stage, we randomly selected two parishes from each of the selected sub-counties. For each parish selected, we randomly selected villages proportionate to the number of villages the parish until the required number of villages was realised. At the third stage, a list of all households with 12-17-year-old adolescent girls was generated for each village. Households from this list were randomly selected until the required sample size was realised for the village.
One adolescent was selected from each household.
Measurements: the dependent variable was the uptake of HPV vaccine which was categorised into two; fully vaccinated and not fully vaccinated. We determined HPV uptake using respondents' recall or vaccination cards if were present. An adolescent was considered fully vaccinated if they had received all the three doses of the HPV vaccine.
Any adolescent who had received one, two or no dose of HPV vaccine was considered not fully vaccinated. The Independent variables included: individual factors, community factors and health service factors. Individual factors included; sociodemographic characteristics, knowledge about the HPV vaccine and attitudes towards HPV vaccine.
We measured knowledge of respondents about the HPV vaccine as a composite variable by asking respondents six questions about the HPV vaccine. The same approach has been used in other studies to measure knowledge levels [11] Table 1 . The knowledge score ranged from 0-6 depending on whether the respondent had passed or failed the question. We considered scores 4-6 as good knowledge about HPV vaccination and scores 0-3 as poor knowledge [12] . We used a three-point Likert scale (2-agree, 1-neither agree nor disagree and 0-disagree) to measure attitudes of respondents towards HPV vaccination using five attitude statements as shown in Table 2 . The attitude score ranged from 0-10 depending on whether the respondent agreed or disagreed to the statement. We considered scores 6-10 as positive attitude towards HPV vaccination and scores ≤ 4 as negative attitude [13] .
Data management and analysis: we reviewed the data for completeness, coded it, and analysed the data using STATA. We computed summary statistics like frequencies, proportions and means of different variables. We then conducted univariable, bivariable and multivariable analysis. At bivariable analysis, we computed prevalence ratios (PR) using a generalised linear model with Poisson family and a log link with robust standard errors as a measure of association because the prevalence of the outcome was above 10%. At multivariable analysis, we included all independent factors with p < 0.10 at bivariable analysis in the multivariable model to obtain adjusted prevalence risk ratios. We used the backward forward elimination with the logical model building approach of considering factors known from literature that affect HPV vaccine uptake to ascertain the best fitting model. Committee. We sought permission to conduct the study from the Lira district and community gatekeepers. Voluntary participation in the study was sought using written informed consent. 
Results

Social demographic characteristics of respondents
Discussion
The study estimated the level of uptake of HPV vaccination at 18% which is below the targeted coverage of 80% required to eliminate common serotypes (i.e., 16 and 18) from targeted populations [14] .
Our result is consistent with results from a study which was conducted among 10th-grade students in Berlin, Germany, 2010. In this study, HPV-vaccine uptake was low. 41.0% of respondents had received the recommended three HPV-vaccine doses [15] . Our findings reveal that attaining an education level of secondary is associated with uptake of Similar associations have been reported by a study conducted among 10th-grade students in Berlin, Germany, where findings revealed that the odds of being fully vaccinated with HPV vaccine decreased with a negative attitude toward vaccinations [15] . Interestingly, we found that receiving the HPV vaccine doses from more than one vaccination site was also a major predictor of complete HPV vaccination status.
Vaccination efforts at some of the HPV vaccination settings can potentially have a markedly greater impact on overall adolescentimmunisation rates than could those at other settings [18] .
A study by Ladner (2012) in the lowest income countries to assess eight HPV vaccination programs that used different modes of HPV vaccination showed that mixed models comprising school and health facility-based vaccination had better overall performance compared to models using just one of the methods [19] . In Lira district, using mixed models of HPV vaccine delivery were important in addressing missed opportunities of receiving HPV vaccination among adolescents. In our study, the prevalence of HPV vaccine uptake was higher among adolescents who had been encouraged by a health worker or a village health team member to go for HPV vaccination.
This result is consistent with findings from a study by Donahue (2015) about HPV vaccine initiation among 9-13-year-olds in the United States. Findings from that study revealed that the strength of health provider recommendation regarding HPV vaccination was a particularly salient predictor of HPV vaccine initiation. Mothers were 21 times more likely to report initiation if they reported that their child´s healthcare provider discussed and recommended HPV vaccination for their child [20] . The success of HPV vaccine delivery depends on high community awareness through Information, education, communication activities as well as counselling [21] .
Community health workers are noble agents of behavioural change and play a key role in the extending formal health services [22] .
Therefore engaging community health workers/VHTs in community HPV mobilisation and sensitisation activities can increase acceptability of the HPV vaccine by adolescents and their parents since they are more trusted by the community members [23] . Furthermore, we found out that there was a 47% higher prevalence of HPV vaccine uptake among adolescents who reported that HPV vaccine community outreaches were conducted in their residences. This result is in agreement with results from a project by PATH (2011) in Nakasongola district, Uganda where parents reported that they were initially reluctant to have their daughters vaccinated because they did not know about cervical cancer or understand the purpose of the HPV vaccines. As they learned more from the community outreaches, they became less reluctant [8] .
Findings from our study revealed that availability of HPV vaccines at vaccination sites on all adolescents' visits is associated with higher prevalence. This result is consistent with a study done by Small (2012) [24] which evaluated the impact of HPV vaccine availability on uptake among 19-to 26-year-old female patients of Planned Parenthood of Mid and South Michigan before and after the vaccine became available at the health centre. Availability of the HPV vaccine increased vaccine uptake from 11% before clinic availability to 16% after availability. Therefore, increasing the availability of the HPV vaccine at vaccination sites substantially improves HPV vaccine uptake among clients. However, improving the availability of the HPV vaccines alone is not sufficient enough for a substantial increase in uptake. Issues of accessibility, including cost and provider recommendation, must also be addressed [25] . Obtaining full information about the HPV vaccine at vaccination sites was positively associated with uptake of the vaccine. This result is consistent with results from a study by Kessels [26] to determine factors associated with HPV vaccine uptake among teenage girls. Results revealed that higher vaccine uptake was associated with having a healthcare provider as a source of information [26] . The major limitation of our study was that the assessed level of uptake might not necessarily explain the efforts of those that received only one or two doses without completing the third dose. Given the fact that we defined the uptake variable in this study as a binary outcome (i.e, fully vaccinated and not fully vaccinated). In our study, there was a possibility of poor recall in remembering the dates on which the vaccines were administered and the durations between each dose. Poor recall was minimised by cross-checking on the vaccination cards if available. The cross-sectional design that was employed limits the making of causal inferences about the main outcome and independent variables.
Conclusion
We found out that the uptake of HPV vaccine was low. What is known about this topic  The study assessed different factors that hinder timely uptake of the HPV vaccine for instance poor attitudes towards the vaccine some of which were already known.
What this study adds
 The study adds an in-depth understanding of the importance of timely vaccination with HPV vaccine and the implications of not receiving the vaccine in time. Tables   Table 1: measurement of knowledge levels about the HPV vaccine of female adolescents in Lira District, Uganda HPV vaccine has no side effects Agreed 2 Total Score = 10, Positive attitudes = scores 6-10, Negative attitudes = scores 0-5 
